Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
DW-1704 by Daewon Pharmaceutical for Chronic Cerebrospinal Venous Insufficiency (CCSVI): Likelihood of Approval
DW-1704 is under clinical development by Daewon Pharmaceutical and currently in Phase III for Chronic Cerebrospinal Venous Insufficiency (CCSVI). According...